A simple risk tool (the OBSERVANT score) for prediction of 30-day mortality after transcatheter aortic valve replacement.

PubWeight™: 1.08‹?› | Rank: Top 10%

🔗 View Article (PMID 24837264)

Published in Am J Cardiol on March 18, 2014

Authors

Davide Capodanno1, Marco Barbanti2, Corrado Tamburino2, Paola D'Errigo3, Marco Ranucci4, Gennaro Santoro5, Francesco Santini6, Francesco Onorati6, Claudio Grossi7, Remo Daniel Covello8, Piera Capranzano2, Stefano Rosato3, Fulvia Seccareccia3, OBSERVANT Research Group

Author Affiliations

1: Division of Cardiology, Ferrarotto Hospital, University of Catania, Catania, Italy; ETNA Foundation, Catania, Italy. Electronic address: dcapodanno@gmail.com.
2: Division of Cardiology, Ferrarotto Hospital, University of Catania, Catania, Italy; ETNA Foundation, Catania, Italy.
3: National Centre for Epidemiology, Surveillance and Health Promotion, Istituto Superiore di Sanità, Rome, Italy.
4: Department of Cardiothoracic and Vascular Anesthesia, Intensive Care Unit, IRCCS Policlinico San Donato, Milan, Italy; Department of Cardiac Surgery, IRCCS Policlinico San Donato, Milan, Italy.
5: Division of Cardiology, Careggi Hospital, Florence, Italy.
6: Division of Cardiac Surgery, University of Verona Medical School, Verona, Italy.
7: Department of Cardiovascular Surgery, S. Croce e Carle Hospital, Cuneo, Italy.
8: IRCCS Department of Anesthesia and Intensive Care, San Raffaele Hospital, Milan, Italy.

Articles by these authors

Impact of off-pump coronary artery bypass grafting on long-term percutaneous coronary interventions. J Thorac Cardiovasc Surg (2015) 3.10

1-Year Outcomes After Transfemoral Transcatheter or Surgical Aortic Valve Replacement: Results From the Italian OBSERVANT Study. J Am Coll Cardiol (2015) 2.70

Acute Kidney Injury With the RenalGuard System in Patients Undergoing Transcatheter Aortic Valve Replacement: The PROTECT-TAVI Trial (PROphylactic effecT of furosEmide-induCed diuresis with matched isotonic intravenous hydraTion in Transcatheter Aortic Valve Implantation). JACC Cardiovasc Interv (2015) 1.44

Transcatheter Aortic Valve Implantation Compared With Surgical Aortic Valve Replacement in Low-Risk Patients. Circ Cardiovasc Interv (2016) 1.41

Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement for Severe Aortic Stenosis in Patients With Chronic Kidney Disease Stages 3b to 5. Ann Thorac Surg (2016) 1.39

Transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis: results from an intermediate risk propensity-matched population of the Italian OBSERVANT study. Int J Cardiol (2012) 0.90

Immediate and Intermediate Outcome After Transapical Versus Transfemoral Transcatheter Aortic Valve Replacement. Am J Cardiol (2015) 0.89

Different impact of sex on baseline characteristics and major periprocedural outcomes of transcatheter and surgical aortic valve interventions: Results of the multicenter Italian OBSERVANT Registry. J Thorac Cardiovasc Surg (2013) 0.82

Early and Midterm Outcome of Propensity-Matched Intermediate-Risk Patients Aged ≥80 Years With Aortic Stenosis Undergoing Surgical or Transcatheter Aortic Valve Replacement (from the Italian Multicenter OBSERVANT Study). Am J Cardiol (2016) 0.82

Effect of severe left ventricular systolic dysfunction on hospital outcome after transcatheter aortic valve implantation or surgical aortic valve replacement: results from a propensity-matched population of the Italian OBSERVANT multicenter study. J Thorac Cardiovasc Surg (2013) 0.79

Comparison of 30-day and 5-year outcomes of percutaneous coronary intervention versus coronary artery bypass grafting in patients aged≤50 years (the Coronary aRtery diseAse in younG adultS Study). Am J Cardiol (2014) 0.79

Thirty-day mortality after coronary artery bypass surgery in patients aged <50 years: results of a multicenter study and meta-analysis of the literature. J Card Surg (2013) 0.78

Meta-analysis on the performance of the EuroSCORE II and the Society of Thoracic Surgeons Scores in patients undergoing aortic valve replacement. J Cardiothorac Vasc Anesth (2014) 0.77

Targeting urocortin signaling pathways to enhance cardioprotection: is it time to move from bench to bedside? Cardiovasc Drugs Ther (2013) 0.77

Transcatheter Aortic Valve Replacement for Severe Aortic Stenosis Patients Undergoing Chronic Dialysis. J Am Coll Cardiol (2015) 0.77

Outcome After General Anesthesia Versus Monitored Anesthesia Care in Transfemoral Transcatheter Aortic Valve Replacement. J Cardiothorac Vasc Anesth (2016) 0.76

Reply: TAVI in Lower Risk Patients: Revolution or Nonsense? Keep Calm and Select Patients. J Am Coll Cardiol (2016) 0.75

Midterm Outcome of Coronary Artery Bypass Grafting in Young Patients: A Multicenter Italian Study. Ann Thorac Surg (2015) 0.75

Results differ between transaortic and open surgical aortic valve replacement in women. Ann Thorac Surg (2013) 0.75

Outcome of emergency coronary artery bypass grafting. J Cardiothorac Vasc Anesth (2014) 0.75

In which patients is transcatheter aortic valve replacement potentially better indicated than surgery for redo aortic valve disease? Long-term results of a 10-year surgical experience. J Thorac Cardiovasc Surg (2013) 0.75

Outcome of Jehovah's Witnesses after adult cardiac surgery: systematic review and meta-analysis of comparative studies. Transfusion (2016) 0.75

Female-specific survival advantage from transcatheter aortic valve implantation over surgical aortic valve replacement: Meta-analysis of the gender subgroups of randomised controlled trials including 3758 patients. Int J Cardiol (2018) 0.75